While this is indicative of promise as an anti-hepatocellular carcinoma agent with an inherent hepatic targeting component, future progress is stunted by the lack of data on absolute bioavailability, the dearth of studies specifically targeted at addressing formulation issues and the comprehensively absence of any type of in vivo metabolic profiling
Jin-Xiong She, PhD, genomic medicine researcher with over 400 published papers
The practical implication is that occasional dosing interruptionswhether planned or accidentalshouldn't significantly impact research outcomes in protocols focused on long-term neuroplasticity rather than acute cognitive performance
Dar HH, Anthonymuthu TS, Ponomareva LA, Souryavong AB, Shurin GV, Kapralov AO
4a, bottom and Supplementary Data 2), suggesting that MZB rely on glycolysis rather than oxidative metabolism at steady-state